2013
DOI: 10.1016/j.toxicon.2013.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant streptavidin-C3bot for delivery of proteins into macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(12 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…Using enzymatically inactive toxin mutants as vaccine carrier is a common method and the most prominent example is the nontoxic mutant CRM197 of DT, which is well established and administered as carrier protein worldwide [34,35]. In this regard, we already demonstrated that different cargo molecules can infiltrate into the cytosol of macrophages or monocytes via C3bot E174Q -mediated transport [55][56][57]. Such an approach might be used to initiate immune responses against cancer cells as discussed for several types of cancers [30].…”
Section: Discussionmentioning
confidence: 99%
“…Using enzymatically inactive toxin mutants as vaccine carrier is a common method and the most prominent example is the nontoxic mutant CRM197 of DT, which is well established and administered as carrier protein worldwide [34,35]. In this regard, we already demonstrated that different cargo molecules can infiltrate into the cytosol of macrophages or monocytes via C3bot E174Q -mediated transport [55][56][57]. Such an approach might be used to initiate immune responses against cancer cells as discussed for several types of cancers [30].…”
Section: Discussionmentioning
confidence: 99%
“…J774A.1 macrophages incubated with biotin-labeled DTA (B-DTA) or with B-DTA, which was previously bound to the transporter molecule C3botE174Q-SA. When B-DTA was delivered into the cytosol by C3botE174Q-SA the cells died, while cells treated with B-DTA alone stayed viable [modified from Christow et al ( 58 )].…”
Section: Molecular and Cellular Consequences Of The C3-catalyzed Rho mentioning
confidence: 99%
“…Prompted by this first successful exploitation of C3 for protein delivery, novel modular transporters based on biotin/streptavidin technology were developed ( 58 , 59 ), as depicted in Figure 2 B. Here, the C3botE174Q moiety mediates the specific transport of streptavidin into the cytosol of monocytes/macrophages.…”
Section: Molecular and Cellular Consequences Of The C3-catalyzed Rho mentioning
confidence: 99%
See 1 more Smart Citation
“…Recently we and others identified monocytes/macrophages as target cells for the C3 protein toxins (~25 kDa) from Clostridium ( C. ) botulinum (C3bot1) and C. limosum (C3lim) (Fahrer et al 2010 ; Dmochewitz et al 2013 ; Christow et al 2013 ; Rotsch et al 2012 ; Tautzenberger et al 2013 ; Rohrbeck et al 2014 ). The clostridial C3 toxins catalyze the covalent transfer of an ADP-ribose moiety from NAD onto Asn-41 of the GTPases Rho A, -B, -C (Aktories and Frevert 1987 ; Aktories et al 1995 ; Just et al 1992 ; Han et al 2001 ; for review see Aktories 2011 ), which inhibits the Rho-mediated signal transduction in mammalian cells (Rubin et al 1988 ; Chardin et al 1989 ; Etienne-Manneville and Hall 2002 ).…”
Section: Introductionmentioning
confidence: 99%